CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2023. “I am proud of our team for driving excellent first quarter results and staying focused…
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for…
Stallergenes Greer, ein biopharmazeutisches Unternehmen, das sich auf die Erforschung, Diagnose und Behandlung von Allergien der Atemwege spezialisiert hat, freut sich, seine strategische Ausrichtung für die Stallergenes Greer Foundation bekannt…
Acuamark Diagnostics has appointed Giulia Kennedy, Ph.D., formerly global chief scientific officer and chief medical officer of diagnostics company Veracyte, to its board of directors. “With sharp intellect, deep humanity and decades of…
Mahana Therapeutics, a leading developer of digital therapeutics designed to empower people with chronic conditions to lead fuller lives, today announced that it has completed Service Organization Control (SOC) 2…
GE HealthCare (Nasdaq: GEHC) announced today the next-generation bkActiv is now available for guiding urology, colorectal and pelvic floor surgical procedures. The flagship intraoperative ultrasound imaging system, developed by BK…
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31,…
A pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company, has adopted REBEL at-line media analyzers in their process development to…
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 21…
Vektor Medical, developer of the vMap® next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American…
Stallergenes Greer, laboratoire biopharmaceutique spécialisé dans la recherche, le diagnostic et le traitement des allergies respiratoires, a le plaisir d’annoncer les orientations stratégiques de sa fondation. La Fondation Stallergenes Greer,…
Stallergenes Greer, a biopharmaceutical company specialising in the research, diagnosis and treatment of respiratory allergies, is pleased to announce its strategic direction for the Stallergenes Greer Foundation. The Stallergenes Greer…